Distinguished High-Tech Executive Sanjay Poonen, Known for Building Multibillion-Dollar Businesses, Joins Tetrate Board of Advisors
Former VMware, SAP executive who serves on the Board of Snyk, and previously served on…
News
Qumu Works with F33.ai to Accelerate Presence in Google Cloud Marketplace
Boosting Enterprise Video Streaming Engagement and Security MINNEAPOLIS–(BUSINESS WIRE)–Qumu Corporation (Nasdaq: QUMU), a leading provider…
Guild Mortgage Simplifies the Path to Sustainable Homeownership with New GreenSmart Advantage Program
Cost of New Energy-Efficient Appliances from The Home Depot Bundled into One Loan, Helping Homebuyers…
Zoom Announces Latest Certifications and Innovations for Enhanced Platform Security
Zoom highlights recent security and privacy efforts with new global third-party certifications and product features…
SCYNEXIS to Present Positive Interim Data from Ongoing FURI and CARES Studies at the 32nd Annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) Being Held April 23-26 in Lisbon, Portugal
Data from studies evaluating ibrexafungerp in serious fungal infections will be presented JERSEY CITY, N.J.,…
NGM Bio to Host the Second of Four Virtual R&D Events on April 27, 2022
NGM831 and NGM438, NGM Bio’s myeloid reprogramming antibody product candidates targeting stromal checkpoints, will be…
Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study
New York, NY, and Tel Aviv, ISRAEL, April 20, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos…
Vericel to Report First-Quarter 2022 Financial Results on May 4, 2022
CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
Eyenovia CEO, CMO and Chairman Dr. Sean Ianchulev to Present at Eyecelerator @ American Society of Cataract and Refractive Surgery (ASCRS) 2022
Presentation to review historic issues related to glaucoma therapies and how these may be addressed…
Certara to Report First Quarter 2022 Financial Results on May 5th, 2022
PRINCETON, N.J., April 20, 2022 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
Jounce Therapeutics to Participate in Raymond James LILRB/ILT Symposium: Deep Dive into “Myeloid Checkpoint” Therapeutics in Cancer
CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage…
Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics
Elusys becomes wholly-owned biodefense subsidiary of NightHawk Plans to expand ANTHIM® distribution abroad DURHAM, N.C.,…
PDS Biotech Chief Medical Officer, Lauren V. Wood, to Chair Session at the World Vaccine Congress
FLORHAM PARK, N.J., April 20, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
OpGen’s Subsidiary Ares Genetics Commercially Launches New Sequencing and Analysis Services Globally
New services include pathogen identification, microbiome profiling and rapid turnaround sequencing of clinical isolates ROCKVILLE,…
Lowell Farms Inc. Becomes Exclusive Distributor of Zippo Products for California Cannabis Dispensaries
Groundbreaking partnership includes debut of Lowell Farms-branded lighters within the Zippo portfolio SALINAS, Calif., April 20,…
Genenta to Host Expert Fireside Chat on Immuno Gene & Cell Therapy for Treatment of Solid Tumors
*** David Reardon, Luigi Naldini, Brad Loncar *** MILAN, Italy and NEW YORK, April 20,…
Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss
Clinical benefit again observed for OTO-413 versus placebo for multiple efficacy endpoints based on responder…
Clover’s Efficacy Data in Previously-Infected Individuals is Published in Lancet Infectious Disease
–94% cumulative protective effect against COVID-19 in previously-infected individuals that subsequently received Clover’s COVID-19 vaccine…
Reduction of share capital
Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital
FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis
– 356 IPF Patients Enrolled – – Topline Data Anticipated Mid-2023 – SAN FRANCISCO, April…